Tech Company Financing Transactions
Labviva Funding Round
Labviva, operating out of Cambridge, secured $25 million from B Capital Group, Biospring Partners and Glasswing Ventures.
Transaction Overview
Company Name
Announced On
1/13/2025
Transaction Type
Venture Equity
Amount
$25,000,000
Round
Series B
Proceeds Purpose
The company intends to use the funds to accelerate product development, bolster marketing and customer support, and expand internationally.
Company Information
Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
1 Bdwy.
Cambridge, MA 02142
USA
Cambridge, MA 02142
USA
Phone
Website
Email Address
Overview
It's simple to choose your lab's reagents, instrumentation and services when the latest science is placed at the heart of purchasing decisions.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Siamak Baharloo
Chief Operating Officer
Aaron Miramontes
Chief Technical Officer
Nicholas Rioux
VP - Bus. Development
Richard Miceli
Browse more venture capital transactions:
Prev: 1/13/2025: Tune Therapeutics venture capital transaction
Next: 1/13/2025: Social Market venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs